Hydrus® Microstent New Enrollment Post-Approval Study

Inclusion Criteria:

• An operable, age-related cataract with best corrected visual acuity (BCVA) of 20/40or worse;

• Diagnosis of primary open angle glaucoma treated with no more than 4 topicalhypotensive medications;

• Optic nerve appearance characteristic of glaucoma;

• Medicated IOP less than or equal to 31 millimeters mercury (mmHg); Otherprotocol-defined inclusion criteria may apply.

Exclusion Criteria:

• Closed angle forms of glaucoma;

• Congenital or developmental glaucoma;

• Secondary glaucoma;

• Use of more than 4 ocular hypotensive medications;

• Previous argon laser trabeculoplasty, trabeculectomy, tube shunts, or any otherprior filtration or cilioablative surgery;

• Prior surgery with implanted device or other surgery involving the trabecularmeshwork or Schlemm's canal;

• Other protocol-defined exclusion criteria may apply.